Loading insider details...
Latest Form 4 (Sep 21, 2026): Exercise/Conversion of 35,000 PHVS shares, $503.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 21, 2026 | Pharvaris N.V. (PHVS) | Exercise/Conversion | 35,000 | $503.6K |
| May 22, 2026 | Pharvaris N.V. (PHVS) | Exercise/Conversion | 10,000 | $80.5K |
| Jan 6, 2026 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Purchase | 10,000 | $34.4K |
| Aug 28, 2025 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Purchase | 10,000 | $34.1K |
| Jul 18, 2025 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Grant/Award | 30,000 | n/a |
| Oct 29, 2024 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Grant/Award | 607 | n/a |
| Jun 20, 2024 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Grant/Award | 23,944 | n/a |
| Jun 26, 2023 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Grant/Award | 25,850 | n/a |
| Jun 16, 2022 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Grant/Award | 47,745 | n/a |
| Jun 16, 2021 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Grant/Award | 12,236 | n/a |